The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Blood Transfusion Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blood collected from the donor has to be screened for a number of infectious disease before transfusion. Thus, blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and healthcare staff.
The global Blood Transfusion Diagnostics market size is expected to reach US$ 4338.7 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Transfusion Diagnostics in various end use industries. The expanding demands from the Hospitals, Clinics, Blood Banks and Laboratories, are propelling Blood Transfusion Diagnostics market. ELISA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NAT segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Transfusion Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Transfusion Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Transfusion Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Transfusion Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Transfusion Diagnostics covered in this report include Grifols, Thermo Fisher Scientific, Roche, bioMérieux, Bio-Rad, Ortho Clinical Diagnostics, Becton Dickinson, Fujirebio and DiaSorin(American Standard Companies), etc.
The global Blood Transfusion Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grifols
Thermo Fisher Scientific
Roche
bioMérieux
Bio-Rad
Ortho Clinical Diagnostics
Becton Dickinson
Fujirebio
DiaSorin(American Standard Companies)
Beckman Coulter
Diagast
Abbott
BAG Health Care
Quidel
Global Blood Transfusion Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Transfusion Diagnostics market, Segment by Type:
ELISA
NAT
Western Blot Assays
Fluorescence Assay
Other Technology
Global Blood Transfusion Diagnostics market, by Application
Hospitals
Clinics
Blood Banks
Laboratories
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Transfusion Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blood collected from the donor has to be screened for a number of infectious disease before transfusion. Thus, blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and healthcare staff.
The global Blood Transfusion Diagnostics market size is expected to reach US$ 4338.7 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Transfusion Diagnostics in various end use industries. The expanding demands from the Hospitals, Clinics, Blood Banks and Laboratories, are propelling Blood Transfusion Diagnostics market. ELISA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NAT segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Transfusion Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Transfusion Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Transfusion Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Transfusion Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Transfusion Diagnostics covered in this report include Grifols, Thermo Fisher Scientific, Roche, bioMérieux, Bio-Rad, Ortho Clinical Diagnostics, Becton Dickinson, Fujirebio and DiaSorin(American Standard Companies), etc.
The global Blood Transfusion Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grifols
Thermo Fisher Scientific
Roche
bioMérieux
Bio-Rad
Ortho Clinical Diagnostics
Becton Dickinson
Fujirebio
DiaSorin(American Standard Companies)
Beckman Coulter
Diagast
Abbott
BAG Health Care
Quidel
Global Blood Transfusion Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Transfusion Diagnostics market, Segment by Type:
ELISA
NAT
Western Blot Assays
Fluorescence Assay
Other Technology
Global Blood Transfusion Diagnostics market, by Application
Hospitals
Clinics
Blood Banks
Laboratories
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Transfusion Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Blood Transfusion Diagnostics
1.1 Blood Transfusion Diagnostics Market Overview
1.1.1 Blood Transfusion Diagnostics Product Scope
1.1.2 Blood Transfusion Diagnostics Market Status and Outlook
1.2 Global Blood Transfusion Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Blood Transfusion Diagnostics Market Size by Region (2018-2029)
1.4 Global Blood Transfusion Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Blood Transfusion Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Blood Transfusion Diagnostics Market Size (2018-2029)
1.6.1 North America Blood Transfusion Diagnostics Market Size (2018-2029)
1.6.2 Europe Blood Transfusion Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Blood Transfusion Diagnostics Market Size (2018-2029)
1.6.4 Latin America Blood Transfusion Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Blood Transfusion Diagnostics Market Size (2018-2029)
2 Blood Transfusion Diagnostics Market by Type
2.1 Introduction
2.1.1 ELISA
2.1.2 NAT
2.1.3 Western Blot Assays
2.1.4 Fluorescence Assay
2.1.5 Other Technology
2.2 Global Blood Transfusion Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Blood Transfusion Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Blood Transfusion Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Blood Transfusion Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Blood Transfusion Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Blood Transfusion Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Blood Transfusion Diagnostics Revenue Breakdown by Type (2018-2029)
3 Blood Transfusion Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Blood Banks
3.1.4 Laboratories
3.1.5 Other
3.2 Global Blood Transfusion Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Blood Transfusion Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Blood Transfusion Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Blood Transfusion Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Blood Transfusion Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Blood Transfusion Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Blood Transfusion Diagnostics Revenue Breakdown by Application (2018-2029)
4 Blood Transfusion Diagnostics Competition Analysis by Players
4.1 Global Blood Transfusion Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Transfusion Diagnostics as of 2022)
4.3 Date of Key Players Enter into Blood Transfusion Diagnostics Market
4.4 Global Top Players Blood Transfusion Diagnostics Headquarters and Area Served
4.5 Key Players Blood Transfusion Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Blood Transfusion Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Grifols
5.1.1 Grifols Profile
5.1.2 Grifols Main Business
5.1.3 Grifols Blood Transfusion Diagnostics Products, Services and Solutions
5.1.4 Grifols Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Grifols Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Blood Transfusion Diagnostics Products, Services and Solutions
5.3.4 Roche Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 bioMérieux Recent Developments
5.4 bioMérieux
5.4.1 bioMérieux Profile
5.4.2 bioMérieux Main Business
5.4.3 bioMérieux Blood Transfusion Diagnostics Products, Services and Solutions
5.4.4 bioMérieux Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 bioMérieux Recent Developments
5.5 Bio-Rad
5.5.1 Bio-Rad Profile
5.5.2 Bio-Rad Main Business
5.5.3 Bio-Rad Blood Transfusion Diagnostics Products, Services and Solutions
5.5.4 Bio-Rad Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Recent Developments
5.6 Ortho Clinical Diagnostics
5.6.1 Ortho Clinical Diagnostics Profile
5.6.2 Ortho Clinical Diagnostics Main Business
5.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Products, Services and Solutions
5.6.4 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Ortho Clinical Diagnostics Recent Developments
5.7 Becton Dickinson
5.7.1 Becton Dickinson Profile
5.7.2 Becton Dickinson Main Business
5.7.3 Becton Dickinson Blood Transfusion Diagnostics Products, Services and Solutions
5.7.4 Becton Dickinson Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Becton Dickinson Recent Developments
5.8 Fujirebio
5.8.1 Fujirebio Profile
5.8.2 Fujirebio Main Business
5.8.3 Fujirebio Blood Transfusion Diagnostics Products, Services and Solutions
5.8.4 Fujirebio Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Fujirebio Recent Developments
5.9 DiaSorin(American Standard Companies)
5.9.1 DiaSorin(American Standard Companies) Profile
5.9.2 DiaSorin(American Standard Companies) Main Business
5.9.3 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Products, Services and Solutions
5.9.4 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 DiaSorin(American Standard Companies) Recent Developments
5.10 Beckman Coulter
5.10.1 Beckman Coulter Profile
5.10.2 Beckman Coulter Main Business
5.10.3 Beckman Coulter Blood Transfusion Diagnostics Products, Services and Solutions
5.10.4 Beckman Coulter Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Beckman Coulter Recent Developments
5.11 Diagast
5.11.1 Diagast Profile
5.11.2 Diagast Main Business
5.11.3 Diagast Blood Transfusion Diagnostics Products, Services and Solutions
5.11.4 Diagast Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Diagast Recent Developments
5.12 Abbott
5.12.1 Abbott Profile
5.12.2 Abbott Main Business
5.12.3 Abbott Blood Transfusion Diagnostics Products, Services and Solutions
5.12.4 Abbott Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Abbott Recent Developments
5.13 BAG Health Care
5.13.1 BAG Health Care Profile
5.13.2 BAG Health Care Main Business
5.13.3 BAG Health Care Blood Transfusion Diagnostics Products, Services and Solutions
5.13.4 BAG Health Care Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 BAG Health Care Recent Developments
5.14 Quidel
5.14.1 Quidel Profile
5.14.2 Quidel Main Business
5.14.3 Quidel Blood Transfusion Diagnostics Products, Services and Solutions
5.14.4 Quidel Blood Transfusion Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Quidel Recent Developments
6 North America
6.1 North America Blood Transfusion Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Blood Transfusion Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Blood Transfusion Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Blood Transfusion Diagnostics Market Dynamics
11.1 Blood Transfusion Diagnostics Industry Trends
11.2 Blood Transfusion Diagnostics Market Drivers
11.3 Blood Transfusion Diagnostics Market Challenges
11.4 Blood Transfusion Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
